You may also like
Terumo Signs Consent Decree with the FDA (Press Release)
During an inspection last year at Terumo Cardiovascular Systems Ann Arbor, Mich., plant, FDA officials found numerous violations to good manufacturing practice and medical device reporting requirements. On March 17, Terumo executive officers signed a consent decree of permanent injunction and under its terms, Terumo will pay almost $35 million in profits from past sales to the federal government.
2 min read
Do We Increase the Operative Risk by Adding the Cox Maze III Procedure to Aortic Valve Replacement and Coronary Artery Bypass Surgery?
The addition of the Cox Maze III procedure to AVR or CABG did not convey an increase in major morbidity and perioperative risk.
2 min read
Five-Year Experience With Mini-Volume Priming in Infants ≤5 kg: Safety of Significantly Smaller Transfusion Volumes
We recommend the use of mini-volume priming,
1 min read